CD79A and COVID-19: Overall, our data, obtained from a sample group from the Tunisian population, showed that COVID-19 RNA vaccines induced the highest levels of IgA and IgG specific antibodies, as compared to alum-adjuvanted inactivated and viral vector vaccines, in SARS-CoV-2-naïve or previously infected individuals.